3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
11
Prostatic Neoplasms
7
Fallopian Tube Neoplasms
5
Neoplasms
3
Breast Neoplasms
3
Prostatic Neoplasms, Castration-Resistant
2
Neoplasm Metastasis
2
Glioblastoma
2
Carcinoma, Ovarian Epithelial
2
Triple Negative Breast Neoplasms
1
Small Cell Lung Carcinoma
1
Prostate Adenocarcinoma
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
1
Metastatic Castration-sensitive Prostate Cancer
1
Lung Neoplasms
1
Hemangiosarcoma
1
Head and Neck Neoplasms
1
Glioma
1
Endometrial Neoplasms
1
Disease Progression
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Neuroendocrine
1
Brain Neoplasms
1
Biliary Tract Neoplasms
1
Interventions
Oxaliplatin
16
Cetuximab
13
Leucovorin
12
Fluorouracil
12
Bevacizumab
10
pembrolizumab
7
Specimen Handling
7
Nivolumab
7
Magnetic Resonance Spectroscopy
6
Irinotecan
6
Capecitabine
6
encorafenib
4
Pemetrexed
4
Gemcitabine
4
Cisplatin
4
cemiplimab
3
Folfox protocol
3
Early Intervention, Educational
3
Carboplatin
3
Biopsy
3
trifluridine tipiracil drug combination
2
relatlimab
2
pertuzumab
2
palbociclib
2
fludarabine
2
durvalumab
2
dehydroftorafur
2
aldesleukin
2
adagrasib
2
X-Rays
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Colonic Neoplasms
×
niraparib
×
90 days
×
Clear all
No trials found.